Condition
Acute Myelogenous Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Acute Myelogenous Leukemia clinical trials that are recruiting, at sites in 3 countries (most in United States (8), Australia (1), China (1)). By phase: Phase 2 (3), Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 3Countries
Newest Acute Myelogenous Leukemia clinical trials
All recruiting trials (8)
-
Adapt NK cells for high-risk AML bridging to stem cell transplant
This study tests an allogeneic NK cell infusion with a brief IL-2 boost in adults with relapsed or refractory AML to see if treatment can help prepare for a future stem cell transplant.
-
Cord blood transplant for children and young adults with blood cancers.
This study will test whether a cord blood transplant given as a first or second transplant can help children and young adults with leukemia, myelodysplasia, or lymphoma who lack a matched donor.
-
Combining an unmodified family (haplo‑identical) donor graft with cord blood for transplant
This trial will test whether giving an unmodified haplo‑identical donor graft followed by a cord blood graft with post‑transplant cyclophosphamide helps people with high‑risk AML, ALL, or MDS stay free of disease.
-
Combining ICP-248 with Azacitidine for treating Acute Myelogenous Leukemia
This study is testing whether a new drug called ICP-248, when combined with azacitidine, can safely help people with Acute Myelogenous Leukemia feel better and improve their treatment outcomes.
-
Study of crushed venetoclax tablets dissolved in liquid for pediatric patients
This study tests if crushing venetoclax tablets and mixing them with liquid helps children with blood cancers absorb the medication better and stay safe while taking it.
-
Monitoring symptoms in cancer patients using remote technology
This study is trying to see how remote technology can help track symptoms in cancer patients with breast, lung, ovarian cancer, multiple myeloma, or acute myelogenous leukemia during their treatment.
-
Stem cell transplant using a specific preparative regimen for blood cancers
This study is testing a new way to prepare for a stem cell transplant using a special combination of medications and radiation to see if it helps people with acute leukemia who are in remission.
-
Collecting and reporting data on patients receiving stem cell transplants
This study is trying to gather and share information about patients getting stem cell transplants for blood cancers to better understand how well these treatments work.
Related topics
Quick answers
How many Acute Myelogenous Leukemia clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (8 trials), Australia (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.